Growth modulation of retinal microvascular cells by early and advanced glycation products

Diabetes Research and Clinical Practice

Volumn 34, Issue 3, 1997, Pages 135-142

  Ruggiero Lopez, Daniel ^a   Rellier, Nadege ^a   Lecomte, Marc ^a   Lagarde, Michel ^a   Wiernsperger, Nicolas ^a  

^a INSERM   (France)

Author keywords

Advanced glycation end products; Diabetes mellitus; Early glycation products; Glycoxidation; Microvascular endothelial cells; Retinal pericytes; Retinopathy

Indexed keywords

BOVINE SERUM ALBUMIN; DNA; GLUCOSE;

ANIMAL CELL; ARTICLE; CATTLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; FETAL CALF SERUM; GLYCATION; GLYCOSYLATION; NONHUMAN; PERICYTE; RETINA BLOOD VESSEL;

ANIMALS; CATTLE; CELL DIVISION; CELLS, CULTURED; DIABETIC RETINOPATHY; ENDOTHELIUM, VASCULAR; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; MICROCIRCULATION; RETINAL VESSELS; SERUM ALBUMIN, BOVINE; TIME FACTORS;

EID: 0031056312     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(96)01352-6     Document Type: Article

References (24)

1. [1] Lorenzi, M. and Cagliero, E. (1991) Pathobiology of endothelial and other vascular cells in diabetes mellitus: call for data. Diabetes 40, 653-659.
2. [2] Kohner, E.M., Porta, M. and Hyer, S.L. (1994) Chronic Complications of Diabetes. Blackwell Scientific, Oxford, pp. 52-62.
3. [3] The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977-986.
4. [4] Chibber, R., Molinatti, P.A., Wong, J.S.K., Mirlees, D. and Kohner, E.M. (1994) The effect of aminoguanidine and tolrestat on glucose toxicity in bovine retinal capillary pericytes. Diabetes 43, 758-763.
5. [5] Porta, M., Molinatti, P.A., Dosso, A.A., Williams, F.M.K, Brooks, R.A. and Kohner, E.M. (1994) Growth of bovine retinal pericytes and endothelial cells in high hexose concentrations. Diabetes Metab. 20, 25-30.
6. [6] Bucala, R., Cerami, A. and Vlassara, H. (1995) Advanced glycosylation end products in diabetic complications. Diabetes Rev., 3, 258-268.
7. [7] Schmidt, A.M., Hori, O., Brett, J., Yan, S.D., Wautier, J.L. and Stern, D. (1994) Cellular receptors for advanced glycation end products. Arterioscler. Thromb. 14, 1521-1528.
8. [8] Wu, V.Y. and Cohen, M.P. (1994) Receptors specific for Amadori-modified glycated albumin on murine endothelial cells. Biochem. Biophys. Res. Commun. 198, 734-739.
9. [9] Cohen, M.P., Hud. E., Wu, V.Y. and Ziyadeh, F.N. (1995) Glycated albumin modified by Amadori adducts modulates aortic endothelial cell biology. Mol. Cell. Biochem. 143, 73-79.
10. [10] Cohen, M.P. and Hud, E. (1989) Production and characterization of monoclonal antibodies against human glycoalbumin. J. Immunol. Methods 117, 121-129.
11. [11] Makita, Z., Vlassara, H., Cerami, A. and Bucala, R. (1992) Immunochemical detection of advanced glycosylation end products in vivo. J. Biol. Chem. 267, 5133-5138.
12. [12] Lecomte, M., Paget, C., Ruggiero, D., Wiernsperger, N. and Lagarde, M. (1996) Docosahexaenoic acid is a major n-3 polyunsaturated fatty acid in bovine retinal microvessels. J. Neurochem. 66, 2160-2167.
13. [13] Nayak, R.C., Herman, A.B., George, K.L., Eisenbarth, G.S. and King, G.L. (1988) A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes. J. Exp. Med. 167, 1003-1005.
14. [14] Labarca, C. and Paigen, K. (1980) A simple, rapid and sensitive DNA assay procedure. Anal. Biochem. 102, 344-352.
15. [15] Vlassara, H., Bucala, R. and Striker, L. (1994) Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab. Invest. 70, 138-151.
16. [16] Lyons, T.J., Li, W., Wells-Knecht, M.C. and Jokl, R. (1994) Toxicity of mildly modified low-density lipoproteins to cultured retinal capillary endothelial cells and pericytes. Diabetes 43, 1090-1095.
17. [17] Bucala, R, Makita, Z., Koschinsky, T., Cerami, A. and Vlassara, H. (1993) Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc. Natl. Acad. Sci. USA 90, 6434-6438.
18. [18] Kalfa, T.A., Gerritsen, M.E., Carlson, E.G., Binstock, A.J. and Tsilibary, E.G. (1995) Altered proliferation of retinal microvascular cells on glycated matrix. Invest. Opthalmol. Vis. Sci. 36, 2358-2367.
19. [19] Monnier, V.M., Vishwanath, V., Frank, K.E., Elmets, C.A., Dauchot, P. and Kohn, R.R. (1986) Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N. Engl. J. Med. 314, 403-408.
20. [20] Hammes, H.P., Martin, S., Federlin, K., Geisen, K. and Brownlee, M. (1991) Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc. Natl. Acad. Sci. USA. 88, 11555-11558.
21. [21] Yamagishi, S., Hsu, C.C., Taniguchi, M. et al. (1995) Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy. Biochem. Biophys. Res. Commun. 213, 681-687.
22. [22] Makita, Z., Radoff, S., Rayfield, E.J. et al. (1991) Advanced glycosylation end products in patients with diabetic nephropathy. N. Engl. J. Med. 325, 836-842.
23. [23] Wautier, J.L., Wautier, M.P., Schmidt, A.M. et al. (1994) Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface associated AGEs and diabetic complications. Proc. Natl. Acad. Sci. USA 91, 7742-7746.
24. [24] Ruderman, N.B., Williamson, J.R. and Brownlee, M. (1992) Glucose and diabetic vascular disease. FASEB J. 6, 2905-2914.